Search results
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 1 day agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
Digital Journal· 3 days agoPRESS RELEASE Published May 22, 2024 ACCESSWIRE Moderna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT CAMBRIDGE, MA / ACCESSWIRE / May 22, 2024 / ...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 4 hours agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
InvestorPlace· 2 days agoModerna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, ...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 19 hours agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 3 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 2 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna Has Big AI News. Is the Stock a Buy? | The Motley Fool
The Motley Fool· 3 days agoThe biotech best known for its billion-dollar coronavirus vaccine has been using this hot technology...
Moderna’s long Covid plan
Politico· 2 days agoModerna is eyeing a new target: long Covid. The pharmaceutical company that became a household name when it developed a Covid-19 vaccine now wants to...